SEER compared with NMRA: revenue, margins and what each company keeps, and the suppliers and customers both name

SEERSeer, Inc.

Mkt capRevenueRevenue

NMRANeumora Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SEERSeer, Inc.

NMRANeumora Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SEER 5

—PrognomiQunlistedcustomer

—Hamiltonunlistedsupplier

—The Brigham and Women's Hospital, Inc. (BWH)unlistedsupplier

—Discovery Life Sciencesunlistedcustomer

1 more · SEER chain ›

Shared 0

No shared counterparties.

Only NMRA 4

AMGNAmgensupplier

—The Scripps Research Institute (TSRI)unlistedsupplier

—Warren Center for Neuroscience Drug Discovery at Vanderbilt Universityunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Vanderbilt

unlistedsupplier

SEERSeer, Inc.

1.63▼−4.05%· post 1.63

Mkt cap$94.1MRevenue$3MQ2 FY26Revenue$17MFY25

NMRANeumora Therapeutics, Inc.

0.48▼−14.65%· post 0.50

ClosedNov 5 '26

Mkt cap$106.3MRevenue—Revenue—

Compare

ClosedNov 5 '26

SEERSeer, Inc.

NMRANeumora Therapeutics, Inc.

1.63▼−4.05%post 1.63

Price

0.48▼−14.65%post 0.50

$94.1M

Mkt cap

$106.3M

Q2 FY26$3M

Revenue

—

FY25$17M

Revenue

—

SEER1.63▼−4.05%vsNMRA0.48▼−14.65%ClosedNov 5 '26